DataTecnica

What DataTecnica does

DataTecnica is a Washington, DC-based biomedical AI and data science company founded in 2017 by Mike Nalls, PhD. The firm operates as a forward-deployed research partner to federal health agencies (NIH, NIA, NINDS, CARD), research foundations (Michael J. Fox Foundation, Aligning Science Across Parkinson's, Chan Zuckerberg Initiative), global consortia (GP2, IPDGC, AMP-PD), and select biotech and pharma organizations (Lilly, Illumina, Flagship Pioneering, Verily). Revenue is generated primarily through long-term professional-services contracts and research collaborations, anchored by the first data-science IDIQ contract in NIH history, awarded in August 2020 for 5-year support of the Center for Alzheimer's and Related Dementias. All major tools are released as open source, and no public pricing is available.

The company's technical portfolio spans AI agents, biomedical benchmarking, harmonized data infrastructure, and domain-specific bioinformatics pipelines. Core assets include BiomedArena.AI (an open live platform for benchmarking LLMs on biomedical tasks), DTAgent-AD (a domain-specialized AI agent fine-tuned for Alzheimer's and neurodegenerative research, achieving 80% Response Quality Rate on CARDBiomedBench), RoP (1.33 million harmonized biomedical Common Data Elements spanning 9+ major vocabularies), The Forge (automated schema harmonization with human-in-the-loop validation), and pipelines for genomics (GenoTools, GenoML), proteomics (ProtPipe), single-cell multiomics (scMAVERICS, IsoMEX), functional genomics (CRISPRbrain, CRISPRlipid), drug target nomination (OmicSynth), and FAIR data tooling (FAIRkit, CARD Catalogue). DataTecnica holds 40+ professionals with deep domain expertise in bioinformatics, clinical analytics, and software engineering. The company is privately held with no disclosed institutional funding, maintains GDPR and EU/Swiss-U.S. Data Privacy Framework certifications for cross-border research, and is a member of the NVIDIA Inception program as of May 2026.

Name

DataTecnica

Legal name

DataTecnica LLC

Website

https://datatecnica.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

DataTecnica is a Washington, DC-based biomedical AI and data science firm that pairs forward-deployed experts with proprietary and open-source tooling to support NIH, global research consortia, and biotech clients in neurodegenerative disease research.

Ownership category

akta.pro rank

Product category

Biomedical AI & Bioinformatics Software

NAICS

Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Computer Programming Services (7371)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO), Data Platform (Unified Data & Analytics) Suites (HDAEABAD)

Keywords

• Biomedical AI software
• Bioinformatics pipelines
• Genomic data analysis
• Clinical data harmonization
• Neurodegenerative disease research

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Government Research Contracts: Long-term agreements with federal health agencies (NIH, NIA) for data science support. Awarded first data science specific IDIQ contract in NIH history in August 2020 for 5-year plan supporting Center for Alzheimer's and Related Dementias.
2. Research Collaboration & Consulting: Pairs forward-deployed subject matter experts with clients to deliver high-quality research results. Serves federal health, biotech and philanthropy sectors with customized analytics and software development.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Core offering

DataTecnica develops AI-powered biomedical research software and provides forward-deployed data science services for neurodegenerative disease research. Its portfolio includes specialized AI agents (DTAgent-AD), harmonized biomedical data assets (RoP with 1.33 million Common Data Elements), open-source bioinformatics pipelines for genomics, proteomics, single-cell, and functional genomics analysis, and an LLM benchmarking platform (BiomedArena.AI). The company delivers these as a combination of open-source tools and contracted research collaborations with NIH, research foundations, and biotech clients.

Product overview

DataTecnica is a healthcare technology company offering a unified portfolio of AI-powered products for biomedical research acceleration. The core platform consists of BiomedArena.AI (LLM benchmarking and evaluation platform) paired with specialized AI agents including DataTecnica Genomics Agent (DTAgent-AD) for neurodegenerative research. Data harmonization is enabled through RoP (1.33M Common Data Elements) and The Forge (automated schema harmonization). The product suite includes specialized pipelines for genomics (GenoTools, GenoML), proteomics (ProtPipe), single-cell analysis (scMAVERICS, IsoMEX), and functional genomics (CRISPRbrain, CRISPRlipid). Supporting tools include OmicSynth for drug target nomination, FAIRkit for FAIR data principles, and the CARD Catalogue for federated resource discovery. All products are deployed in collaboration with NIH, academic institutions, and pharmaceutical partners to advance open science in neurodegenerative and neurological diseases.

Differentiator

Problem solved

Functional benefit

Brands

• BiomedArena.AI: Open, live platform for benchmarking LLMs on biomedical research tasks, developed in partnership with LMArena and NIH CARD
• RoP (Registry of Things)
• GenoML
• GenoTools
• CRISPRbrain
• CRISPRlipid
• OmicSynth
• scMAVERICS
• FAIRkit
• IsoMEX
• ProtPipe
• The Forge

Products and services

• BiomedArena.AI Open, live platform for benchmarking large language models on biomedical research tasks, integrating General Biomed (PubMed, Google search) and Genomics (NCBI datasets, GWAS summary statistics, pharmacogenomics databases) knowledge modes. Offers Knowledge Mode for domain-specialized agents and serves AI/ML researchers evaluating biomedical LLMs.
• DataTecnica Genomics Agent (DTAgent-AD) A specialized biomedical AI agent for Alzheimer's disease and neurodegenerative research, available via Knowledge Mode on BiomedArena.AI. Features multi-step reasoning, integrated memory, and grounded literature synthesis for genetics, pharmacogenomics, biomarker discovery, and patient stratification tasks. Built for biomedical researchers and AI developers.
• RoP (Registry of Peptides/Phenotypes) An open-source collection of 1.33 million harmonized biomedical Common Data Elements with semantic embeddings, value sets, and governance parameters built on OMOP, LOINC, ICD-10, HPO, Mondo, and 9 other major vocabularies. Enables multi-cohort research interoperability for academic medical researchers, consortia, and data harmonization teams.
• The Forge

Quantifiable outcome

• 40-70% of researcher time saved on data wrangling through pre-harmonized CDEs and AI-assisted tooling
• +6 more outcomes

Named customers15 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature13 records

Partnerships

18 partnerships are on record, tiered core and notable.

• NVIDIA Inception ProgramcoreTechnology or Integration · 18 May 2026DataTecnica announced membership in the NVIDIA Inception program in May 2026. Already accelerating new workflows in biomedical research with more GPU optimization to come. Program provides startups with tools, expertise, and go-to-market support for AI innovation.
• LMArenacoreStrategic or Co-development Partner · 19 August 2025Partnership with LMArena to expand BiomedArena as a domain-specific evaluation track built on CARDBiomedBench. Aims to create a dedicated, community-driven platform for evaluating and advancing language models tailored to the biomedical domain. Provides open access evaluation, public leaderboard, and interfaces for researchers to contribute.
• NIH Center for Alzheimer's and Related Dementias (CARD)coreStrategic or Co-development PartnerLong-term strategic partnership for building open science tools for accelerating neurodegenerative disease research. 5-year agreement to support CARD's vision. Collaborated on CARDBiomedBench benchmark development and DTAgent-AD agent training. DataTecnica contributes forward deployed teams to CARD initiatives.
• NIH National Institute on Aging (NIA)coreStrategic or Co-development PartnerLong-term agreement since March 2017 to support data science at NIA's Laboratory of Neurogenetics. Collaborates with International Parkinson's Disease Genomics Consortium. Analyzes biobank scale datasets and supports AMP-PD infrastructure.
• Global Parkinson's Genetics Program (GP2)coreStrategic or Co-development PartnerProvides SaaS, data engineering and domain expertise to GP2 project. Contributed to Release 7 with 54,180 genotyped participants. Led by Michael J. Fox Foundation with support from NIH, ASAP, and Verily.
• International Parkinson's Disease Genomics Consortium (IPDGC)coreStrategic or Co-development PartnerAnalyzes data across international research centers for Parkinson's genetics. Led hackathons and contributed to major GWAS studies including 90 risk loci discovery.
• Michael J. Fox FoundationcoreStrategic or Co-development PartnerCollaborator on Parkinson's disease research. Provided fellowship experience for team member Hirotaka Iwaki in managing massive datasets in the pharma, medical and academic space.
• Kampmann Lab (UCSF)notableStrategic or Co-development PartnerUnique collaboration between DataTecnica and Kampmann Lab to develop CRISPRbrain.org data commons. Developed by scientists for scientists. Kampmann Lab provided exceptional feedback and collaborative standards for scientific/engineering collaboration.
• Olzmann Lab (UC Berkeley)notableStrategic or Co-development PartnerCollaboration to develop CRISPRlipid.org, a community-driven resource for exploring functional genomic screens related to lipid/membrane biology. Led by Faraz Faghri from DataTecnica team.
• VerilycoreTechnology or IntegrationGP2 Release 7 hosted on Verily Workbench and Terra platform. Provides cloud infrastructure for large-scale genetic data processing and analysis.
• Answer ALSnotableStrategic or Co-development PartnerCollaborative study contributing to multi-modal data harmonization and federated open science initiatives.
• SEA-ADnotableStrategic or Co-development PartnerCollaborative study contributing to Alzheimer's disease research through Path-ND Consortium and 10,000 Brains Project.
• UK Dementia Research Institute (UKDRI)notableStrategic or Co-development PartnerCollaborator on sleep and brain health research combining data from Wales, Finland and UK biobanks in study of 2M+ individuals.
• OHDSI (Observational Health Data Sciences and Informatics)notableTechnology or IntegrationUpstream standard contributor. RoP built on OMOP common data model developed by OHDSI for observational health data analytics.
• Regenstrief Institute (LOINC)notableTechnology or IntegrationUpstream standard contributor. RoP incorporates LOINC terminology standards for laboratory observations and measurements.
• Monarch Initiative (HPO, Mondo)notableTechnology or IntegrationUpstream standard contributor. RoP incorporates Human Phenotype Ontology (HPO) and Mondo disease ontology for standardized phenotyping.
• NIH NINDS-CDEnotableTechnology or IntegrationUpstream standard contributor. RoP incorporates NINDS Common Data Elements for standardized neurological research data collection.
• GA4GH (Global Alliance for Genomics and Health)notableTechnology or IntegrationUpstream standard contributor. RoP incorporates DUO (Data Use Ontology) for standardized data use conditions in genomic research.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• DNAnexus: Cloud-based biomedical informatics platform providing data management, analysis pipelines, and collaboration tools for genomics and clinical research. Directly comparable to DataTecnica as both serve large-scale genomic data infrastructure needs for consortia and pharma with similar cloud-hosted, multi-omic offerings.
• Velsera (formerly Seven Bridges): Bioinformatics and clinical genomics platform supporting multi-omic analysis, federated learning, and data harmonization for research consortia and pharma. Closely overlaps with DataTecnica's GenoTools, The Forge, and federated analysis capabilities for large cohort programs.
• Lifebit Biotech: Federated genomics and biomedical data platform used by research consortia for secure, cloud-based analysis of large genomic and clinical datasets. Direct competitor in federated analysis, common data models (OMOP), and consortia-focused bioinformatics services.
• BC Platforms: Genomic data management and analytics platform combining biobank data, EHR harmonization, and pharma R&D enablement. Comparable to DataTecnica in providing harmonized CDE infrastructure and pharma-facing analytical services for large-scale genomic research.

Emerging players

• Owkin: AI-for-drug-discovery company building biomedical foundation models and federated learning tools across multiple therapeutic areas. Comparable to DataTecnica's AI agent roadmap (DTAgent-AD) and federated ML capabilities, though focused on oncology and immunology rather than neurodegeneration.
• Insitro: Machine-learning-driven drug discovery company combining genomics, phenotypic data, and AI for therapeutic target identification. Comparable to DataTecnica's OmicSynth drug-target nomination thesis, though Insitro operates an internal pipeline rather than open-science consortium work.
• Arctus Therapeutics: Early-stage AI biotech developing therapeutics for neurodegenerative diseases using multi-omic and genetic insights. Comparable as a downstream consumer of the same kind of open-science genetics and multi-omic outputs that DataTecnica helps generate through GP2 and consortia work.

Broad incumbents

• Datavant: Health data connectivity and de-identification platform enabling linking of clinical and research datasets across institutions. Comparable to DataTecnica's The Forge / RoP data harmonization capabilities, though broader in scope and much larger in scale.
• Verily (Alphabet): Alphabet-owned precision health company operating the Terra platform and Verily Workbench for genomic and clinical research. Listed as a customer/partner of DataTecnica (GP2 hosting) but also a competitor providing similar cloud-based genomics infrastructure to research consortia.
• Illumina: Dominant DNA sequencing and genomics technology vendor with expanding bioinformatics and AI offerings (Illumina Connected Analytics, PrimateAI). Listed as a DataTecnica collaborator but also a competitor in providing end-to-end genomics pipelines and AI-driven interpretation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/datatecnica
• LinkedInlinkedin.com/company/datatecnica

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DataTecnica